DB
Dash Bio, Inc.
SEC filingOther Health Care · Boston, MA
Amount raised$30Msold at filing
Total offering$30M
Investors in the raise9count reported to the SEC
FiledJul 14, 2026first sale Jun 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David JohnsonExecutive Officer, Director
Alexander TallettExecutive Officer, Director
Andy SmithDirector
Executive officers, directors and promoters as listed on the Form D.